Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Blue Stream Labs Expands ADC Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Blue Stream Labs Expands ADC Capabilities

ADC field is expanding, generating a lot of interest and opportunities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Blue Stream Laboratories, an analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services, is expanding its antibody-drug conjugates (ADC) capabilities. ADCs are a growing class of drugs that use high-targeting antibodies to deliver potent anti-cancer drugs. ADCs can target and deliver higher doses to specific tumor markers, while eliminating side effects common with chemotherapy.
 
“The ADC field is expanding and, thus, generating a lot of interest and opportunities. By increasing our ADC capabilities, Blue Stream is building on nearly a decade’s worth of experience in the characterization of recombinant protein therapeutics including dozens of projects across many biologic drug conjugates,” said Mario DiPaola, Ph.D., chief scientific officer of Blue Stream Laboratories.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics